These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 20550598)

  • 21. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis.
    Bay K; Hartung S; Ivell R; Schumacher M; Jürgensen D; Jorgensen N; Holm M; Skakkebaek NE; Andersson AM
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3410-8. PubMed ID: 15755855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive regulation of the Insl3 gene in rat Leydig cells.
    Sadeghian H; Anand-Ivell R; Balvers M; Relan V; Ivell R
    Mol Cell Endocrinol; 2005 Sep; 241(1-2):10-20. PubMed ID: 16006031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral INSL3 concentrations decline with age in a large population of Australian men.
    Anand-Ivell R; Wohlgemuth J; Haren MT; Hope PJ; Hatzinikolas G; Wittert G; Ivell R
    Int J Androl; 2006 Dec; 29(6):618-26. PubMed ID: 17014531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-Butyl) phthalate.
    McKinnell C; Sharpe RM; Mahood K; Hallmark N; Scott H; Ivell R; Staub C; Jégou B; Haag F; Koch-Nolte F; Hartung S
    Endocrinology; 2005 Oct; 146(10):4536-44. PubMed ID: 16037377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like factor 3: a novel circulating hormone of testicular origin in humans.
    Ferlin A; Foresta C
    Ann N Y Acad Sci; 2005 May; 1041():497-505. PubMed ID: 15956751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic effects of testosterone and the endocrine disruptor mono-(2-ethylhexyl) phthalate on INSL3 transcription in Leydig cells.
    Laguë E; Tremblay JJ
    Endocrinology; 2008 Sep; 149(9):4688-94. PubMed ID: 18499751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel hormone INSL3 is expressed in human testicular Leydig cell tumors: a clinical and immunohistochemical study.
    Rossato M; Tavolini IM; Calcagno A; Gardiman M; Dal Moro F; Artibani W
    Urol Oncol; 2011; 29(1):33-7. PubMed ID: 19110449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nuclear receptors in INSL3 gene transcription in Leydig cells.
    Tremblay JJ; Robert NM
    Ann N Y Acad Sci; 2005 Dec; 1061():183-9. PubMed ID: 16467267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu.
    Bay K; Main KM; Toppari J; Skakkebæk NE
    Nat Rev Urol; 2011 Apr; 8(4):187-96. PubMed ID: 21403659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paracrine and endocrine roles of insulin-like factor 3.
    Ferlin A; Arredi B; Zuccarello D; Garolla A; Selice R; Foresta C
    J Endocrinol Invest; 2006; 29(7):657-64. PubMed ID: 16957417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptorchidism and endocrine disrupting chemicals.
    Virtanen HE; Adamsson A
    Mol Cell Endocrinol; 2012 May; 355(2):208-20. PubMed ID: 22127307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for kit receptor signaling in Leydig cell steroidogenesis.
    Rothschild G; Sottas CM; Kissel H; Agosti V; Manova K; Hardy MP; Besmer P
    Biol Reprod; 2003 Sep; 69(3):925-32. PubMed ID: 12773427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INSL3 as a biomarker of Leydig cell functionality.
    Ivell R; Wade JD; Anand-Ivell R
    Biol Reprod; 2013 Jun; 88(6):147. PubMed ID: 23595905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network.
    Facondo P; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A
    Protein Pept Lett; 2020; 27(12):1246-1252. PubMed ID: 32981493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In utero exposure to mono-n-butyl phthalate impairs insulin-like factor 3 gene expression and the transabdominal phase of testicular descent in fetal rats.
    Shono T; Shima Y; Kondo T; Suita S
    J Pediatr Surg; 2005 Dec; 40(12):1861-4. PubMed ID: 16338306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of insulin-like peptide 3 in the postnatal rat Leydig cell lineage: timing and effects of triiodothyronine-treatment.
    Mendis-Handagama SM; Ariyaratne HB; Mrkonjich L; Ivell R
    Reproduction; 2007 Feb; 133(2):479-85. PubMed ID: 17307915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis.
    Anand-Ivell RJ; Relan V; Balvers M; Coiffec-Dorval I; Fritsch M; Bathgate RA; Ivell R
    Biol Reprod; 2006 May; 74(5):945-53. PubMed ID: 16467492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecular basis for estrogen-induced cryptorchidism.
    Nef S; Shipman T; Parada LF
    Dev Biol; 2000 Aug; 224(2):354-61. PubMed ID: 10926772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of testosterone and insulin-like peptide 3 secretions in response to human chorionic gonadotropin in cultured interstitial cells from scrotal and retained testes in dogs.
    Pathirana IN; Ashida Y; Kawate N; Tanaka K; Tsuji M; Takahashi M; Hatoya S; Inaba T; Tamada H
    Anim Reprod Sci; 2011 Mar; 124(1-2):138-44. PubMed ID: 21377298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of insulin-like factor 3, anti-Mullerian hormone, inhibin B, and testosterone during pubertal transition in healthy boys: a longitudinal pilot study.
    Johansen ML; Anand-Ivell R; Mouritsen A; Hagen CP; Mieritz MG; Søeborg T; Johannsen TH; Main KM; Andersson AM; Ivell R; Juul A
    Reproduction; 2014; 147(4):529-35. PubMed ID: 24459206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.